Transforming HCMV Immunotherapy
Explore the groundbreaking potential of Dense Bodies technology
Pioneering Immunotherapy Breakthroughs
Preclinical Insights
Enhancing Protective CD8 T-Cell Therapy
Our therapeutic vaccination approach significantly boosts CD8 T-cell therapy for cytomegalovirus in hematopoietic cell transplant patients, offering a promising advancement in immune protection.
Shielding Against Viral Challenges
Immunization with recombinant Dense Bodies effectively protects healthy mice from intense viral exposures, demonstrating robust defensive capabilities.
Boosting Adoptive T-Cell Therapy
Dense Bodies enhance the effectiveness of adoptive T-cell therapy, supporting stronger immune responses in treated patients.
Stronger Antibody Reactions
Modified Dense Bodies from an enhanced Towne strain of cytomegalovirus trigger a potent neutralizing antibody response, improving immune defense.
Significant T-Cell Growth
Dense Bodies stimulate remarkable expansion of CD8+ T cells in transplant recipients, leading to a more than 1000-fold increase in cell count.
Our Development Journey
Q3 2025
Initiate Technology Transfer and Establish Feasibility Assays
Q3 2026
Produce Toxicity Batches and Conduct Preclinical Safety Studies
Q3 2027
Secure Clinical Trial Approvals and Ethics Clearance
Q3 2028
Scale Up Manufacturing with GMP Standards, Launch Phase 1A with Healthy Volunteers, and Proceed to Phase 1B with Transplant Patients
Why Select Dense Bodies?
Comprehensive Antigen Profile
Dense Bodies encompass all relevant antigens, ensuring thorough immune coverage.
Robust Immune Responses
They excel in eliciting powerful cellular and humoral immune reactions.
Congenital CMV Potential
Dense Bodies hold significant promise for preventing congenital cytomegalovirus.
Exceptional Immunogenicity
They demonstrate outstanding ability to provoke immune responses.
Broad Variant Protection
Dense Bodies offer defense against a wide range of viral variants.
Long-Lasting Efficacy
They ensure sustained immune effectiveness over time.
Rapid Immune Activation
Dense Bodies deliver quick onset of immune response.
Witness Our Innovation
Discover the intricate structure of Dense Bodies, revealed through advanced electron microscopy, at the heart of our pioneering immunotherapy research.
Ready to Explore Further?
Learn how Dense Bodies can redefine HCMV immunotherapy.
Contact Us